Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10174 |
5-R-Rivaroxaban
|
Factor Xa | Metabolism |
5-R-Rivaroxaban 是一种 Rivaroxaban 的 R 型对映体。其中 Rivaroxaban 是选择性的Factor Xa(FXa) 抑制剂。 | |||
T4980 |
Betrixaban maleate
|
Factor Xa | Metabolism |
Betrixaban maleate 是一种非维生素 K 口服抗凝剂,其作用是由 Xa 因子的竞争性和可逆抑制作用驱动的。 | |||
T1184 |
Rivaroxaban
BAY 59-7939,利伐沙班 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Rivaroxaban (BAY 59-7939) 是高效选择性的凝血因子 Xa (FXa) 直接抑制剂,IC50=0.7 nM,Ki 为 0.4 nM。 | |||
T1736 |
Apixaban
阿哌沙班,BMS-562247-01 |
Factor Xa | Metabolism |
Apixaban (BMS-562247-01) 是一种高度选择性,可逆的、口服具有活力的凝血因子 Xa (Factor Xa) 抑制剂,抑制人和兔凝血因子 Xa 的 Ki 分别为 0.08 nM 和 0.17 nM。它可以用于研究各种血栓栓塞疾病。 | |||
T0372 |
Gabexate mesylate
甲磺酸加贝酯,FOY |
Factor Xa; Serine Protease; Proteasome | Metabolism; Proteases/Proteasome; Ubiquitination |
Gabexate mesylate (FOY) 是一种非抗原的类胰蛋白酶丝氨酸蛋白酶抑制剂。 | |||
T4341 |
Betrixaban
贝曲西班,PRT054021 |
Factor Xa | Metabolism |
Betrixaban (PRT054021) 是一种口服具有活力的选择性factor Xa(fXa) 抑制剂,IC50=1.5 nM。 | |||
T22323 |
Enoxaparin sodium
|
Thrombin | Proteases/Proteasome |
Enoxaparin sodium 是一种低分子量肝素 (LMWH),已获得美国 FDA 批准,可用于医疗管理的 ST 段心肌梗死 (STEMI) 或 STEMI 及随后的经皮冠状动脉介入治疗 (PCI) 患者。它与抗凝血酶结合并增强其作用,并抑制凝血因子 XIa、IXa、Xa 和 IIa(凝血酶),从而防止血栓形成。 | |||
T31206 |
Darexaban
YM 150,Darexaban, Tanexaban,YM150 |
Factor Xa | Metabolism |
Darexaban (Tanexaban, YM-150) 是选择性的、口服具有活力的 Xa 因子 (FXa) 抑制剂,IC50=54.6 nM。它对其他相关丝氨酸蛋白酶(如胰蛋白酶、凝血酶和激肽释放酶)具有高选择性。它具有抗凝和抗血栓形成作用。 | |||
T8362 |
Benzamidine hydrochloride
Benzamidine HCl,苄脒盐酸盐 |
Serine/threonin kinase; Serine Protease | Cell Cycle/Checkpoint; Metabolism; Proteases/Proteasome |
Benzamidine hydrochloride (Benzamidine HCl) 是可逆的胰蛋白酶样丝氨酸蛋白酶 (trypsin-like serine proteases) 竞争性抑制剂,对 uPA、类胰蛋白酶、胰蛋白酶和 Xa 因子作用的Ki 分别为 97 µM、20 µM、21 µM 和 110 µM。 | |||
T4076 |
Fondaparinux sodium
Natural heparin pentasaccharide Sodium,Fondaparin sodium,磺达肝素(癸)钠,磺达肝癸钠,SR-90107A,Arixtra |
Factor Xa | Metabolism |
Fondaparinux sodium (SR-90107A) 是抗凝血酶依赖性的 factor Xa 抑制剂。 | |||
T2368 |
Edoxaban Tosylate Monohydrate
DU-176b,DU-176b tosylate Monohydrate,Lixiana,Edoxaban,依度沙班对甲苯磺酸盐一水化合物 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Edoxaban Tosylate Monohydrate (DU-176b tosylate Monohydrate) 是口服具有活力的 factor Xa 选择性抑制剂。它是一种抗凝剂,可用于预防中风,是一种凝血酶和凝血因子 IXaβ (FIXa) 的弱抑制剂,对 FXa 的选择性超过 10000 倍。它具有抗血栓形成的特性,可用于血栓栓塞性疾病的研究。 | |||
T67853 |
Rivaroxaban Impurity
Rivaroxaban-10 |
Factor Xa | Metabolism |
Rivaroxaban Impurity (Rivaroxaban-10) 是一种强效凝血因子Xa 抑制剂,IC50=66 nM。 | |||
T27257 |
EMD-503982
EMD 503982 |
||
EMD-503982 is a factor Xa inhibitor. | |||
T20454 |
4-Chlorophenylurea
NSC12971,NSC 12971,NSC-12971,4-氯苯基脲 |
Factor Xa | Metabolism |
4-Chlorophenylurea (NSC-12971) 是一种新型口服生物可利用的 Xa 因子抑制剂。 | |||
T27920 |
LY 517717
LY-517717,LY517717 |
Factor Xa | Metabolism |
LY 517717 是一种具有口服活性的凝血因子 Xa 抑制剂,具有抗血栓活性,可用于研究静脉血栓栓塞(VTE)。 | |||
T31668 |
Eribaxaban
PD 348292,PD0348292,PD-0348292,PD-348292,PD 0348292,PD348292 |
Factor Xa | Metabolism |
Eribaxaban (PD348292) 是一种可口服的 Xa 因子抑制剂,可用于预防和治疗静脉血栓栓塞。 | |||
T27318 |
Fidexaban
CI-1031,BX-807834,PD-200022,CI1031,BX807834,ZK-807834 |
Factor Xa | Metabolism |
Fidexaban (CI1031) 是一种新型、强效、选择性和口服活性 Xa 因子抑制剂,在多种测定中均显示出抗血栓活性。 | |||
T4690 |
Betrixaban hydrochloride(330942-05-7(free base))
PRT054021 hydrochloride,盐酸贝曲西班 |
Factor Xa | Metabolism |
Betrixaban hydrochloride(330942-05-7(free base)) (PRT054021 hydrochloride) 是一种有效的、选择性的、口服有效的 Xa 因子 (fXa) 抑制剂 (IC50: 1.5 nM)。 | |||
T29215 |
Zifaxaban
TY 602,TY602,TY-602 |
Factor Xa | Metabolism |
Zifaxaban (TY-602) 是一种具有口服活性、竞争性和选择性的 Xa 因子 (FXa) 抑制剂,对人 FXa 的 IC50 为 11.1 nM。Zifaxaban 的亲和力很高,比其他丝氨酸蛋白酶高 10000 倍以上。Zifaxaban 可用于研究动脉和静脉血栓形成。 | |||
T78215 |
Dechloro Rivaroxaban
|
Factor Xa; Others | Metabolism; Others |
Dechloro Rivaroxaban 是一种具有口服活性和高选择性的 Factor Xa 抑制剂。Dechloro Rivaroxaban 对人体内游离 FXa 的抑制作用显著。Dechloro Rivaroxaban 对凝血酶原以及纤维蛋白相关的 FXa 活性也有抑制效果。 | |||
T66256 |
Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
|
Factor Xa | Metabolism |
Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 对凝血因子Xa具有抑制作用,可用于研究血栓性静脉炎、动脉粥样硬化、脑栓塞、中风、肺栓塞。 | |||
T68092 |
Letaxaban
TAK-442 |
Factor Xa | Metabolism |
Letaxaban (TAK-442) 是一种口服活性的四氢嘧啶-2(1H)- 1衍生物和具有抗凝血活性的凝血因子Xa(激活因子X)抑制剂。Letaxaban 不影响出血时间。Letaxaban 已被用于研究静脉血栓栓塞和急性冠状动脉综合征的治疗和预防的试验。 | |||
T2368L |
Edoxaban
Lixiana,依杜沙班 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Edoxaban (Lixiana) (DU-176) 是一种选择性的,口服有效的 factor Xa (FXa)抑制剂。Edoxaban 对游离 FXa 和凝血酶原的 Ki 分别为 0.561 nM 和 2.98 nM。Edoxaban 是一种抗凝剂,可用于预防中风。Edoxaban 还是一种凝血酶和凝血因子 IXaβ (FIXa) 的弱抑制剂,Ki 值分别为 6.00 μM 和 41.7 μM,对 FXa 的选择性超过 10000 倍。由于具有抗血栓形成的特性,Edoxaban 可用于预防血栓栓塞性疾病的研究。 | |||
T70536 |
Idraparinux Na
|
||
Idraparinux Na is an Antithrombotic, Indirect, Selective, Synthetic Factor Xa Inhibitor | |||
T27224 |
DX-9065A HCl hydrate
DX9065,DX 9065,DX9065A,DX 9065A,DX-9065A,DX-9065 |
||
DX-9065A is a factor Xa inhibitor. DX-9065a inhibits proinflammatory events induced by factor Xa and gingipains. DX-9065a is a competitive inhibitor of the Spectrozyme FXa (SpFXa) cleavage by both fXa and prothrombinase with similar K(i) values of approxi | |||
T70349 |
DJT06001
|
||
DJT06001 is a selective Factor Xa inhibitor, reducing thrombus formation with low risk of bleeding. | |||
T35926 |
Bz-IEGR-pNA (acetate)
|
||
Bz-IEGR-pNA is a colorimetric substrate for Factor Xa.1 Factor Xa preferentially binds to and cleaves the Ile-Glu-Gly-Arg (IEGR) peptide sequence to release p-nitroanilide (pNA), which can be quantified by colorimetric detection at 405 nm as a measure of Factor Xa activity.References1. Aruell, L., Friberger, P., Karlsson, G., et al. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb. Res. 11(5), 595-609 (1977). Bz-IEGR-pNA is a colorimetric substrate for Fact... | |||
T26793 | BI-11634 | ||
BI-11634 is a factor Xa inhibitor. | |||
T69276 | KFA1982 | ||
KFA1982 is a novel and potent factor Xa inhibitor. | |||
T27698 |
JTV-803 mesylate
JTV803,JTV 803,JTV-803 |
||
JTV-803 is a factor Xa inhibitor. JTV-803 showed a competitive inhibitory effect on human factor Xa, with a K(i) value of 0.019 microM and IC(50) value of 0.081 microM. JTV-803 was 100 times more selective in inhibiting human factor Xa as compared to its | |||
T71096 |
GCC-4401C methanesulfonate
|
||
GCC-4401C methanesulfonate is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). | |||
T21037 |
Edoxaban Isomer
|
||
Edoxaban Isomer is an impurity of Edoxaban, which is a novel inhibitor of factor Xa. | |||
T35931 |
GGACK (hydrochloride)
|
||
GGACK is an inhibitor of urokinase-type plasminogen activator (uPA) and factor Xa (Kis = 1.8 and 8.7 μM, respectively).1,2 1.Kettner, C., and Shaw, E.The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketoneBiochim. Biophys. Acta569(1)31-40(1979) 2.Kettner, C., and Shaw, E.The selective affinity labeling of factor Xa by peptides of arginine chloromethyl ketoneThromb. Res.22(5-6)645-652(1981) | |||
TP1129 |
Boc-Ile-Glu-Gly-Arg-AMC
IEGR-AMC |
||
Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC), a specific, highly fluorogenic substrate for clotting enzyme factor Xa (coagulation factor Xa). Boc-IEGR-AMC is also hydrolyzed by acrosin from the ascidian Halocynthia roretzi. | |||
T37054 |
Z-D-Arg-Gly-Arg-pNA . 2 HCl
|
||
Z-RGR-pNA is a chromogenic substrate for the determination of factor Xa. | |||
T23755 |
AS1468240
AS 1468240,AS-1468240 |
||
AS1468240 is a factor Xa inhibitor. It has significant oral anticoagulant activity. | |||
T27202 |
DPC-423
DPC-423 Free |
||
DPC-423 is a factor Xa inhibitor potentially for the treatment of thrombosis. | |||
T27121 |
Darexaban glucuronide
YM 222714,YM222714,YM-222714 |
||
Darexaban glucuronide is the major component in plasma after oral administration of darexaban to humans. Darexaban (YM150) is a direct inhibitor of factor Xa. | |||
T28921 |
Tanogitran
BIBT 986,BIBT986,BIBT-986 |
||
Tanogitran, a coagulation factor Xa inhibitor, is used potentially for the treatment of septic shock. | |||
T12694 |
Razaxaban hydrochloride
BMS 561389 hydrochloride,DPC 906 hydrochloride |
Others | Others |
Razaxaban hydrochloride is a highly potent, selective and orally active inhibitor of factor Xa(Ki of 0.19 nM),has strongly antithrombotic activity. | |||
T12782 |
RWJ-445167
3DP-10017 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
RWJ-445167 is a thrombin and factor Xa dual inhibitor(Ki of 4.0 nM and 230 nM, respectively), with potent antithrombotic activity. | |||
T38795 |
Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA hydrochloride
|
||
Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA hydrochloride is a factor Xa specific chromogenic substrate. | |||
T27514 |
GW-813893
GW813893,GW 813893,GSK813893,GSK-813893,GSK 813893 |
||
GW-813893 is a potent, selective and orally active factor Xa inhibitor. GW813893 inhibited FXa and prothrombinase activity with a Ki of 4.0 nM and 9.7 nM, respectively. | |||
T70184 |
YM-60828 dihydrochloride
|
||
YM-60828 dihydrochloride is a Factor Xa (FXa) inhibitor and anticoagulant used in the treatment of venous thromboembolic disease. | |||
T78424 |
CH3OCO-D-CHA-Gly-Arg-pNA acetate
|
Factor Xa | Metabolism |
CH3OCO-D-CHA-Gly-Arg-pNA acetate是一种用于检测factor Xa活性的显色底物。 | |||
T71429 |
O-Demethyl apixaban sulfate
|
||
O-Demethyl apixaban sulfate is a metabolite of Apixaban, a potent and highly selective factor Xa inhibitor. Apixaban is currently under development for treatment of arterial and venous thrombotic diseases. | |||
T28491 |
R-1663
R1663 |
||
R-1663 is a factor Xa inhibitor. R-1663 prolonged clotting times, inhibited thrombin generation (peak height and endogenous thrombin potential [ETP]) and anti-factor Xa activity in a concentration-dependent manner without increasing bleeding time. Pharmac | |||
T10820 |
Ciraparantag
PER977 |
Others | Others |
Ciraparantag is an inhibitor of thrombin and factor Xa. Ciraparantag is a broad-spectrum reversal agent for anticoagulants, including unfractionated heparin, low-molecular-weight heparin, and certain direct oral anticoagulants. | |||
T71362 |
GCC-4401C free base
|
||
GCC-4401C free base is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). | |||
T37176 | Edoxaban impurity 6 | ||
Edoxaban impurity 6 is an impurity of Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention[1][2]. [1]. Furugohri T, et al. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost. 2008 Sep;6(9):1542-9.[2]. Mendell J, Lee F, Chen S, The Effe... |